Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers

NCT03026855 is registered in ClinicalTrials.gov with TotipotentRX Cell Therapy Pvt. Ltd. as lead sponsor.

NCT NCT03026855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03026855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers
Lead sponsor
TotipotentRX Cell Therapy Pvt. Ltd.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
May 31, 2016
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic ulcer